Haemonetics narrows FY25 adjusted EPS view to $4.50-$4.70 from $4.45-$4.75

Consensus $4.59. Narrows FY25 adjusted operating margin to 24% from 23%-24%. Lowers FY25 free cash flow view to $120M-$140M from $130M-$180M.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue